相关实验视频
Updated: Jan 10, 2026

13:34
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
8.8K
痴呆症是晚期发作的主要并发症
Dong Won Kwack1, Dong Wook Kim1
1Department of Neurology, Konkuk University Medical Center, Seoul, Korea.
Epileptic disorders : international epilepsy journal with videotape
|November 21, 2025
概括
痴呆症是老年人晚发性的重要危险因素. 这项研究发现,患有痴呆症的老年患者在年龄较大时经历了发作,并且比患有中风后的人更容易患上抑郁症.
科学领域:
- 老年病的医生 老年病的医生
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 在老年人中更为普遍,通常与神经疾病如中风和创伤性脑损伤有关.
- 痴呆症在这个人群中被怀疑是的原因,但由于其高患病率,其确切的贡献很难确定.
研究的目的:
- 研究伴随性痴呆症的老年患者的临床特征.
- 将这些特征与患有中风后或来源不明的的老年患者进行比较.
主要方法:
- 一项对494名新诊断患有的老年患者 (≥65岁) 的回顾性研究.
- 患者被分为三个组:中风后 (194),并发性痴呆症 (105) 和未确定的病因 (71).
- 分析了临床特征,发作和先前存在的疾病,并在各组之间进行了比较.
主要成果:
- 与其他组相比,伴随性痴呆症患者在发作和最后一次治疗时年龄较大.
- 痴呆症患者的抑郁率和先前使用痴呆症药物 (乙胆酶抑制剂,美曼丁) 的比例较高.
- 在中风后的患者中,中风风险因素比较普遍,如高血压和脂质失调.
结论:
- 痴呆症可能是老年人晚发性的重要并发症和危险因素.
- 区分老年人的病病因对于了解疾病机制和患者管理至关重要.
相关概念视频
Dementia
498
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
498
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Glutamate Antagonists
865
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
865
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K

